Member Info for TrekMadone

..should focus any cash raise to being accretive. With revenues and over £4m in cash they are covered for ops so I only see any raise for distribution of portfolio.

Apologies hit the post button earlier.

Atb all.

Trek

Burton,

Thanks for the link. I couldn’t stand the purgatory any longer and just bought in. I really like the CEO comes over very business like with clear objectives and how.

If they get ovarian, breast and prostrate on the same early detection platform then this could go to £5 very quickly. I know I could have bought at 77p and today paid 1.35 but that’s just the way it goes. I’m just looking at the MCAP of 84m with 28m from US going to over 40m and revenue from China and Russia yet to kick in and that’s just cdt lung!

I have kept some back in case there is a pull back after such a strong run but whatever this is imo significantly under valued. it’s good to see directors with a decent holding which

Armchair Trader,

More on the link but only what we know...

“Touchstone Exploration unaffected by coronavirus

Touchstone Exploration’s activities slowed down only moderately during the corona outbreak as Trinidad managed to pass largely unscathed by the virus. Trinidad has had a total of 123 cases since the beginning of the pandemic and only 8 deaths, allowing for businesses and operations to return back to normal before many other locations.

Unlike other Caribbean islands where most of the foreign currency income stems from tourism, Trinidad and Tobago is far more industrialized andit is an established location for oil exploration and extraction. Spain’s largest oil producer Repsol has been operating in the country since 1995 with four offshore production blocks and a major gas discovery made in 2017.

For Touchstone Exploration the next step will be additional drilling and production at Cascadura as part of fully understanding what lies below the surface to optimising future production plans. Petroleum Consultants GLJ are due to complete an independent reserves evaluation in July. The firm’s next set of results is due at the end of June.”

https://www.thearmchairtrader.com/touchstone-exploration-shares/

There’s an old saying, don’t put all your eggs in one basket. A new saying for stoners is I wish I had!

Trek

Actually I have. Thanks

And never posted ill of anyone and just tried to share some experience. Others could have sliced at £2. All had same chance. I didn’t conceal it. I just sold more today, like many. Hopefully it goes back up tomorrow. Atb

Trek

Jim Sparked

“You are one massive bum hole... what a prick you are”

Thanks Jim Sparkes, I was always top goal scorer. Had the right attitude and focus and never got wound up.

I did say that I’m still invested.

Just don’t fight the market ‘it can remain irrational longer than you are solvent”

Anyways like I said I hope it comes back up tomorrow. ATB

Trek

Thanks Global,

I’ve been in this game long enough to have learnt the hard way.

I still have a holding here in profit but now I have options. If this rockets to £2 on the right news I will average back in at £2. Some folk just don’t get that but it’s what you sell for that counts.

Atm I have left 20% in so that gives me more than 4 equal hits (as sold higher) to have another go latter but the cash is protected in case it goes back to the 80s.

I do hope though that there is a decent bounce to 120 especially for all the PrimaryBid guys. ATB

Trek

Well that was a ride! I sold most of mine on the way down Friday and today. Don’t matter what I or AS says it’s the market that’s the judge.

First 9 rules of investing are all the same. Protect your capitol! The 10th is back the BoD! Lol!

A RNS announcing distribution deals ain’t gonna cut it.

A Rns saying LFD prototype works will help, but then it’s not gonna be market ready until ‘late summer’ at best. Nothing ready from end of may/June

Getting a partner for affimer is probably best short term driver but even that tech is a way off.

I’ve left a decent amount to average back in depending on the landscape but I’m glad I took £26k out for the car at a touch under £2!

Lots of opportunities elsewhere atm. Hope it bounces back up and I don’t mind paying more later if the news is better but for now just gotta live to fight another day.

Trek

You can buy at 7.55 sell at 7.4 but only sell 3000 else NT. I added another 50k at 7.55 will show up in a bit.

Looks like there’s still a few to offload at these prices. Hoping this is the bottom now!

Trek

RD,

Are you proposing that Cytiva load Sona’s nano rods with AVCT Affimer beads? A possibility but that is not what the lab reports indicate and Global are running with the original Sona LFD.

Trek

Ok you are kinda missing my point.

Take on CERP,

Milk the assets!

Sell the cream!

Finance #P1,

Cover 2nd drill.

Cerp is expendable!

Trek

My apologies I forgot the link.

Ref

https://sonanano.com/sona-nanotech-provides-covid-19-antigen-test-progress-update/

Trek

Hi Ophidian,

While you are looking in... What do you maketh of this, below. Affimers are agnostic to temperatures. Sona have imo been in a tiz over it...

“Further testing will be conducted both in-house and independently using pre-treated viral samples after recent independent testing using virus samples that were de-activated by heat did not provide a response. Exposing a virus to high heat levels can modify its characteristics, making the treated virus sample an inappropriate proxy for a live sample. These findings, coupled with previous hospital-based experiments, have suggested that testing using a live viral culture and/or patient sampling will be required for ultimate confirmation of the effectiveness of the Sona test. The Company expects to confirm further third party validation testing, specific to its device needs, in the near future...

FDA are particular about temperature ranges, my earlier post.

Anyways interested in your views.

Trek

Hi OaW,

I just saw your post after posting my ill informed research which will get lost as it’s data and not opinion, lol! Anyways, well said my virtual friend!

Too many rampers and sycophants here imo, whilst I don’t include RK in that statement per se as we all have a tendency, self included, to plug a little too much and it needs to be, MUST, be called out! Fair play for doing so!

Conversely the deramping side needs a kick but hey, I personally think that’s more helpful as you just check your data and it helps to be challenged. Probably why the SAVE BB is the best on LSE (IMO) as you can’t get away with FA and just about everyone is critically optimistic! Lol! ATB.

Trek

Post 2 submission criterion...

“Human Usability Study: for home-collection and mailing the sample to a CLIA-certified lab for testing:

• Testing should include a minimum of 30 participants and takes place in an actual use environment or simulated environment.
• The entire workflow should be performed by each individual participant using the kit, including kit registration, sample collection, packaging of the sample, and mailing to the laboratory with pre-prepared label.
• The participants should be observed (either in person or by remote visual monitoring, such as a video conference) during sample collection and all difficulties should be noted.
• After the entire process is completed the user should be given the questionnaire to indicate the ease of use of the kit and sample collection as well as understanding the consequences if steps are not performed correctly. The participant should be able to provide comments if needed.
• The laboratory personnel should inspect the packaging and sample upon delivery and note all packaging errors and acceptability of the sample for testing.
• The samples collected during the study should be tested for specimen adequacy using a human sample control assay. This could include using an EUA authorized assay that includes a human sample control (e.g. RNaseP) to determine if sufficient sample was collected by the user. Alternatively, the laboratory could run a separate RT PCR for each sample that targets a human housekeeping gene. A design feature of the collection device, such as changing color in the presence of human material, may also be an appropriate control.
• Participants should include individuals representing varying education levels and ages. Participants with prior medical or laboratory training should be excluded. Participants who have prior experience with self-collection should be excluded.
• The study should have pre-defined acceptance criteria and defined strategy to mitigate risk of errors identified in the study (e.g., modifying the instructions).
We encourage sponsors to submit their usability study protocols and questions for participants for FDA review prior to conducting the study.”

So needs a mini study...

Trek

Hi Ophidian,

Thank you for your insights.

Re the earlier antibody test link I wasn’t sure 66 tests would cut it as antigen is more complex. I have been through the FDA EUA page looking for similarities.

https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization

and this is the first using AND sputum. All rest are nasal....

“AQ-TOP COVID-19 Rapid Detection Kit SEASUN BIOMATERIALS, Inc.

Qualitative detection of nucleic acid from SARS-CoV-2 upper and lower respiratory specimens including oropharyngeal and nasopharyngeal swab specimens, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens, bronchoalveolar lavage (BAL) and sputum from individuals who are suspected of COVID-19 by their healthcare provider....”

Ref..
https://www.fda.gov/media/138300/download

Saesun look to be a subsidiary of Datametrex AI..

Ref...
https://www.marketscreener.com/DATAMETREX-AI-LIMITED-49479241/news/Datametrex-AI-Two-COVID-19-Test-Kits-Distributed-by-Datametrex-Granted-FDA-Emergency-Use-Authoriza-30744634/

So I look at the template and realise that Sputum is different from Saliva! Oh the joys of an ignorant PI!

“This template is intended for home collection kits for anterior nares swab or saliva specimens; if you are considering other types of respiratory specimens (e.g., sputum, throat/tongue swabs, or nasal aspirates) or non-respiratory specimens (e.g., stool, etc.), please contact FDA at CDRH-EUA-Templates (CDRH-EUA-Templates@fda.hhs.gov) to discuss your validation strategy.”

Ref...

https://www.fda.gov/media/138412/download

Anyways therein lie criterion for FDA EUA...

So I looked at home tests..

“The proposed study design is for validation of home sample collection for nasal swab samples in media (you should test all media you intend to use for shipping), or saliva.Testing should include 20 spiked samples at 2xLoD (low positives) and 10 spiked samples at 5-10x LoD (high positives)...”

So the minimum is 30. But, please forgive I can’t find the link again, I remember seeing Sona doing 700 ish via Global..

Anyways on the next post is the submission criterion. So Avct need a ‘mini study’. I do think AS was somewhat naive in his comments at interview about the tolerances. Sure the process is straightforward as long as the results stack up! I’m bullish but balanced, I hope!

Trek

Hi Greens,

It’s really a simple case of cerp needing cash to develop assets, that ‘is’ now bpc’s problem. The way they are financing is by equity. Printing more shares. So even if they drill and get success at #p1 the spoils are shared across more shares so less upside.

This is oil, obviously, and even if they drill there is a likelihood of needing a second drill or sidetrack. Cerps finances are not up to paying for that.

There is also now the macro exposure to POO. You will know that txp stored oil during the price backwardation because they were savy and had facilities. I don’t know if cerp could sustain another hit to oil price + they need to finance the pf.

All of this needs more cash. Look thinking out of the box the only way this makes sense to me is if they can on sell cerps pf to finance #p1. Now that would be smart if they know of a buyer and with the likes of Shell, BP and Exxon in area that would be possible. They may be interested in the cream and Bpc can park everything else until #p1 is done.

Remember where you heard it first! Lol!

Trek

Hi Ophidian,

Re point 7. Would you have any knowledge of the scale of trials. How many test? I’m just asking to take a read across from the Sona timeframe.

Thanks

Trek

I made my views known on the finances after the finals, my concerns for funding #P1 were not popular, fair enough but now you add CERP into the mix. They have basically capitulated to this offer as it’s the only offer for cash. It all comes down to finance in the end. BPC must have had a heads up that the dilution will be financed from someone(s). I don’t see PI’s financing this, we are just the mugs that will suffer the dilution. Expect another string of complex financial instruments to protect those higher tier investors.

I have looked at cerp and bought txp. Cerp’s financial risk put me off.

I was here for a big drill and hope of a farm in, the upside and likelihood of both have now been diluted because BPC will now have even more cash distractions.

I’m sitting this out now until spud when I may buy a punt and probably take a view on selling some/all before TD. I just see that as a way of missing all the complexities and riding the drill.

Shame it’s come to this after all these years. Kids been through school and all grown up and I held BPC pretty much all that time. Luckily I actually made money here by taking bags out on the spikes and buying the dips. Oh well! ATB

Trek

Absolutely OaW and there will be a significant market for it, universities being an obvious candidate.

The comments are a generalisation to expect such a device, not necessarily gdr’s.

Trek

One for the list ‘universities’ especially in USA. Cashed up, medical facilities on site just need a mass quick test. Step up GDR...

“How realistic do you think it will be to get all students and faculty and staff members tested before they come onto campus in some cases in August? In some cases that’s tens of thousands of people.....”

Easy with GDR poc PCR based test! And probably such a scenario is better suited to a central testing point and cheaper than lateral flow device.

“... with the newer tests coming online this summer, particularly the antigen test, you could literally test thousands of thousands of people reasonably expeditiously. I’m not sure you could do that today or tomorrow, but we’re told that as we get into the late spring, early summer, that those types of tests would be available.”

https://www.chronicle.com/article/does-anthony-fauci-think/248839/#.Xs0oPm_0GNw.twitter

Link from zoom on avct bb.

Trek